Transforming growth factor β1 as an indicator of the progression of chronic viral hepatitis
Journal Title: Postępy Nauk Medycznych - Year 2010, Vol 23, Issue 1
Abstract
Transforming growth factor b1 (TGF b1) is main cytokine responsible for progression of fibrosis in chronic liver disease. Factors having impact on progression in chronic viral hepatitis (cvh) are not clearly identified.The aim of the study was to evaluate factors having influence on progression of fibrosis in cvh.Hepatic concentration of TGF b1 (Quantikine Immunoassay Kit) was measured in 78 patients: 52 with cvh C, 19 with cvh B, 7 with non alcoholic fatty liver disease and autoimmune hepatitis. The results were analyzed in relation to grade of inflammation and necrotic changes as well as stage of fibrosis in histological analysis of liver bioptates (according to Batt and Ludwig’s scale), insulin resistance (HOMA-IR>2.259), serum alanine aminotransferase (ALT), asparagine aminotransferase (AST) and g-glutamyltranspeptydase (g-GTP) activity, HCV and HBV viral load, sustained viral response to interferon a therapy in cvh C (SVR), body mass index (BMI), adipose tissue amount and presence of metabolic syndrome (EGIR 1999).There was correlation between TGF b1 and inflammatory-necrotic process activity on the basis of histological examination (p<0.00001), ALT activity (p=0.0177), degree of fibrosis (p=0.0002). TGF b1 concentration was statistically significantly higher in patients with liver steatosis (p=0.0144), elevated g-GTP activity (p=0.0296), and insulin resistance (p=0.057).No statistically significant difference was found in TGF b1 concentration in relation to the rest of analyzed factors.The results confirmed close correlation between TGF b1 and progression of liver injury as well as correlation between progression of cvh and liver steatosis, insulin resistance and oxydative stress resulting in increase of serum g-GTP activity.
Authors and Affiliations
Andrzej Cieśla, Tomasz Mach, Krystyna Pierzchała-Koziec, Joanna Zubel, Paweł Skwara
Keywords
Related Articles
- EP ID EP53736
- DOI -
- Views 191
- Downloads 0
Treatment of coagulopathies in severe liver disease
Coagulopathy in patients with severe liver disease results from multiple abnormalities in the haemostatic system. The most important is reduced plasma levels of both procoagulative and anticoagulative factors synthesized...
Ostra białaczka szpikowa – współczesne poglądy na patogenezę, postępowanie diagnostyczne, klasyfikację, stratyfikację prognostyczną i leczenie
W ciągu ostatniej dekady dokonał się istotny postęp w zakresie wiedzy dotyczącej molekularnej patogenezy ostrej białaczki szpikowej (OBSz), jak również w identyfikacji nowych markerów diagnostycznych i czynników rokownic...
Multicentre studies in which the Department of Cardiology of the Postgraduate Medical School participated – their contribution to contemporary treatment of acute coronary syndromes
Cardiovascular diseases, especially coronary artery disease and its most acute phase myocardial infarction, are prevalent causes of mortality in developed populations. Contemporary treatment of acute coronary syndrome is...
Mięsień szkieletowy w starości - od zmian neurogennych po toksyczny wpływ leków
Proces starzenia dotyczy wszystkich tkanek i narządów w organizmie człowieka, w tym również mięśni szkieletowych. Systematyczne zmniejszanie się zarówno siły jak i masy mięśni negatywnie wpływa na sprawność ruchową osób...
Treatment with the thyroid hormone – is it a challenge?
Levothyroxine (L-T4) represents the first-line treatment in patients with primary andcentral hypothyroidism in different periods of life. Although the normal thyroid glandsecretes both thyroxine and triiodothyro nine, cu...